EnWave Reports 2025 Second Quarter Consolidated Interim Financial Results

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2025.

Alle Werte sind in Tausend und in CAD angegeben, sofern nicht anders angegeben.

• Reported revenue for Q2 2025 of $3,689, an increase of $3,026 relative to the comparable period in the prior year. The increase was primarily related to a large-scale machine sale and the commissioning of two small-scale machines.
• Reported royalty revenues for Q2 2025 of $474, an increase of $60 relative to the comparable period in the prior year. Royalties grew due to increased royalty partners, product sales, and partner production for the quarter.
• Gross margin for the three months ending Q2 2025 was 33% compared to (25)% for the three months ending Q2 2024. The increase in margin was a result of higher machine sales, royalties, and tolling revenue for the quarter.
• Reported an increase in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $10 for Q2 2025 relative to the comparable period in the prior year, with the increase primarily related to recruitment fees.
• Reported Adjusted EBITDA⁽¹⁾ income for Q2 2025 of $112, an increase of $1,380 from the comparable period in the prior year.

Konsolidierte finanzielle Leistung:

Note: (1) Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

Der konsolidierte Zwischenabschluss und die MD&A von EnWave sind auf SEDAR+ unter www.sedarplus.caund auf der Website des Unternehmens www.enwave.net verfügbar.

Key Financial Highlights for the Six Months Ended March 31, 2025 (expressed in 000’s)

• Reported revenue of $4,866, an increase of $2,941 relative to the comparable period in the prior year. The increase was primarily related to additional machine sales. 
• Reported Royalty revenues of $1,033, an increase of $139 or 16% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
• Reported an increase in SG&A costs of $14 for the six months ending March 31, 2025, relative to the comparable period in the prior year, with the increase primarily related to tradeshow attendance and recruitment fees offset by reduced legal costs associated with the capitalization of the Term Loan and Credit facility issuance costs.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $523 for the six months ended March 31, 2025, an increase of $1,501 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q2 2025 and Subsequently:

• Signed a Technology Evaluation and License Option Agreement with Solve Solutions LTDA of Brazil.
• Signed a License Agreement Amendment with BranchOut Food Inc. for the exclusive rights to produce dried blueberry products using EnWave’s REV^TM technology in Peru.
• Signed a License Agreement Amendment with Patatas Fritas Torres S.L. of Spain to expand the product portfolio to focus on commercializing healthy, protein-rich snack products.
• Signed an Equipment Purchase Agreement and License Amendment with Sprouted Proteins for a 10kW REV™ machine and the grant of exclusive rights to produce certain starch-based snack products.
• Signed an Equipment Purchase Agreement and Commercial Licence Agreement with Hokkai Yamato Foods for a 10kW REV^TM  machine.
• Signed a Master Service Agreement and First Work Order with Bio Technique LLC to evaluate EnWave’s REV^TM dehydration technology.
• Signed an Equipment Purchase Agreement and Licence Agreement Amendment with MicroDried® for a 60kW REV™ machine and the exclusive rights to use REV^TM technology for apple ingredient production in Washington, Oregon, and Idaho.
• Received the Second Progress Payment related to the Equipment Purchase Agreement with Procescir S.A. de C.V. of Mexico for 120kW Radiant Energy Vacuum Machinery.
• Signed a License Agreement Amendment with Creations Foods US Inc. for an additional right to produce dried cheese snacks for pet treat applications on a non-exclusive basis in the United States. 
• The Company recognized a $836 USD tax refund for NutraDried during the quarter in discontinued operations.  The tax refund was for the Employee Retention Tax Credit which is a refundable tax credit from the United States government for businesses that were affected during the COVID-19 pandemic.  The Company does not expect to receive any additional tax refunds or credits related to NutraDried.
• The Company appointed its first international Business Development Manager, based in the Netherlands. This new Business Development Manager will play a pivotal role in strengthening the Company’s international presence and accelerating growth in the European market.
• Subsequent to the quarter, the Company repurchased a 10 kW REV™ machine and 120kW REV™ machine from an Illinois, U.S. based cannabis company. The transaction increases inventory levels and strengthens the Company’s position to deliver on partnership opportunities, expediting the fulfillment and revenue recognition of prospective REV™ machine sales.  

Nicht-IFRS-Finanzkennzahlen:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring income and expenses, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management.  Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca

Über EnWave

EnWave ist weltweit führend in der Innovation und Anwendung der Vakuum-Mikrowellentrocknung. Von seinem Hauptsitz in Delta, BC, aus hat EnWave ein solides Portfolio an geistigem Eigentum entwickelt, seine Radiant Energy Vacuum (REV™)-Technologie perfektioniert und eine innovative Idee in eine bewährte, konsistente und skalierbare Trocknungslösung für die Lebensmittel-, Pharma- und Cannabisindustrie umgewandelt, die herkömmliche Trocknungsmethoden in Bezug auf Effizienz, Kapazität, Produktqualität und Kosten bei weitem übertrifft.

With more than fifty royalty-generating partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

Die Strategie von EnWave besteht darin, lizenzpflichtige kommerzielle Lizenzen mit Lebensmittelherstellern zu unterzeichnen, die besser, schneller und wirtschaftlicher als mit Gefriertrocknung, Gestelltrocknung und Lufttrocknung trocknen wollen und von den folgenden Vorteilen profitieren: Herstellung aufregender neuer Produkte, bis zu siebenmal schnelleres Erreichen des optimalen Feuchtigkeitsgehalts und Verbesserung von Geschmack, Textur, Farbe und Nährwert der Produkte.

Erfahren Sie mehr unter EnWave.net.

EnWave Gesellschaft

Herr Brent Charleton, CFA

Präsident und Geschäftsführer

Für weitere Informationen:

Brent Charleton, CFA, Präsident und CEO unter +1 (778) 378-9616
E-Mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO unter +1 (778) 870-0729
E-Mail: dmurray@enwave.net  

Safe Harbour für zukunftsgerichtete Informationen: Diese Pressemitteilung kann zukunftsgerichtete Informationen enthalten, die auf den Erwartungen, Schätzungen und Prognosen der Geschäftsleitung basieren. Alle Aussagen, die sich auf Erwartungen oder Prognosen über die Zukunft beziehen, einschließlich Aussagen über die Wachstumsstrategie des Unternehmens, die Produktentwicklung, die Marktposition, die erwarteten Ausgaben und die erwarteten Synergien nach dem Abschluss der Transaktion, sind zukunftsgerichtete Aussagen. Für die Richtigkeit aller Angaben Dritter, auf die in dieser Mitteilung Bezug genommen wird, wird keine Gewähr übernommen. Alle Verweise Dritter auf Marktinformationen in dieser Mitteilung sind ohne Gewähr, da das Unternehmen die ursprünglichen Primärrecherchen nicht durchgeführt hat. Diese Aussagen sind keine Garantie für zukünftige Leistungen und beinhalten eine Reihe von Risiken, Ungewissheiten und Annahmen. Obwohl das Unternehmen versucht hat, wichtige Faktoren zu identifizieren, die dazu führen könnten, dass die tatsächlichen Ergebnisse wesentlich abweichen, kann es andere Faktoren geben, die dazu führen, dass die Ergebnisse nicht wie erwartet, geschätzt oder beabsichtigt ausfallen. Es kann nicht garantiert werden, dass sich solche Aussagen als zutreffend erweisen, da die tatsächlichen Ergebnisse und zukünftigen Ereignisse erheblich von den in solchen Aussagen erwarteten abweichen können. Dementsprechend sollten sich die Leser nicht zu sehr auf zukunftsgerichtete Aussagen verlassen.

Weder die TSX Venture Exchange noch ihr Regulierungsdienstleister (gemäß der Definition dieses Begriffs in den Richtlinien der TSX Venture Exchange) übernehmen die Verantwortung für die Angemessenheit oder Richtigkeit dieser Pressemitteilung.